Kidney Function Panel

Your kidneys filter roughly 180 liters of fluid from your blood every day, silently managing waste removal, blood pressure, mineral balance, and acid control. When they start to fail, there are no early warning signs. No pain. No obvious changes in how you feel. By the time symptoms like swelling or fatigue appear, you may have already lost more than half your kidney function. An estimated 37 million adults in the United States have chronic kidney disease (CKD), and about 9 in 10 of them do not know it.

A single kidney marker, like creatinine alone, can miss early damage entirely, especially in people with more or less muscle mass than average. This panel combines filtration markers, waste products, electrolytes, and metabolic signals to reveal how your kidneys are actually performing across every job they do. That combination is what turns a basic lab number into a real clinical picture.

What This Panel Reveals

The panel covers three distinct domains of kidney health: filtration capacity, mineral and acid balance, and metabolic stress signals. No single test spans all three. Together, they catch problems that any one test alone would miss.

Filtration: How Well Your Kidneys Clean Your Blood

The filtration markers in this panel, creatinine, cystatin C, and the estimated glomerular filtration rate (eGFR) they generate, answer the most basic question about your kidneys: how efficiently are they removing waste? Creatinine is a byproduct of muscle metabolism that the kidneys clear at a steady rate. When kidney function drops, creatinine rises. But creatinine is heavily influenced by muscle mass, diet, and body composition. A muscular person can have elevated creatinine with perfectly healthy kidneys. A frail or elderly person can have normal creatinine despite significant kidney damage.

Cystatin C solves this problem. It is a small protein produced by nearly every cell in the body at a constant rate, and its blood level is far less affected by muscle mass, age, sex, or diet. A 2021 study in the New England Journal of Medicine showed that combining creatinine and cystatin C into a single eGFR equation (the CKD-EPI 2021 equation) produces more accurate filtration estimates than either marker alone. The combined equation also eliminated the need for race-based adjustment factors that had been a source of clinical concern.

The 2024 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend cystatin C confirmation whenever creatinine-based eGFR falls between 45 and 59, because this is the range where creatinine alone most often misclassifies people. Having both markers drawn in the same panel means you get the most accurate filtration estimate in a single visit.

Waste Clearance: Reading the BUN Signal

Blood urea nitrogen (BUN) is a waste product from protein breakdown, cleared by the kidneys. Unlike creatinine, BUN is also affected by how much protein you eat, whether you are dehydrated, and how well your liver is working. That sensitivity is actually useful. When BUN rises out of proportion to creatinine, it often points to dehydration or increased protein breakdown rather than kidney disease itself. When both rise together, the kidneys themselves are the likely problem.

Mineral and Acid Balance: The Kidney's Hidden Jobs

Filtering waste is the kidney's most famous job, but it is not the only one. Your kidneys also maintain the precise concentrations of sodium, potassium, calcium, phosphorus, and bicarbonate in your blood. When kidney function declines, these electrolytes shift in predictable patterns, often before the filtration markers themselves look alarming.

Phosphorus tends to rise as the kidneys lose the ability to excrete it. Research has shown that in people with CKD, higher serum phosphorus is independently associated with faster progression to kidney failure and with increased cardiovascular mortality, even at levels still within the standard reference range. Calcium may drop as phosphorus rises, because the two minerals are locked in a seesaw relationship regulated by parathyroid hormone and vitamin D activation, both of which depend on kidney function.

Bicarbonate drops when the kidneys cannot excrete enough acid. This state, called metabolic acidosis, accelerates muscle wasting, bone loss, and kidney disease progression. A randomized trial published in the Journal of the American Society of Nephrology showed that correcting low bicarbonate in CKD patients slowed the decline in kidney filtration by roughly two-thirds over two years compared to standard care. That makes bicarbonate one of the most actionable numbers on this panel.

Potassium and sodium round out the electrolyte picture. Potassium levels that are too high or too low increase the risk of dangerous heart rhythms. Sodium reflects hydration status and hormone signaling. Together with the other electrolytes, they reveal how well the kidney's regulatory machinery is working.

Metabolic Stress: What Glucose and Albumin Add

Glucose is on this panel because diabetes is the leading cause of kidney disease worldwide, responsible for roughly 40% of all new cases of kidney failure in the United States. An elevated fasting glucose on a kidney panel is not just a metabolic finding; it is a direct risk factor for the organ system you are screening. Catching elevated glucose alongside early kidney changes lets you connect cause and effect in real time.

Albumin, the most abundant protein in blood, is made by the liver and reflects both nutritional status and kidney function. As CKD advances, albumin levels often drop due to chronic inflammation and poor nutrition. Low albumin in a person with declining eGFR is a strong predictor of poor outcomes. In large observational studies of CKD populations, even modestly reduced serum albumin has been independently associated with higher all-cause mortality, with risk rising steeply as albumin drops further.

How to Read Your Results Together

Individual results matter, but patterns across multiple markers tell a more complete story. Here are the most common patterns you should know how to recognize.

A rising phosphorus paired with a falling calcium, especially alongside a declining eGFR, signals that the kidneys are losing their ability to manage mineral metabolism. This pattern often appears in CKD stage 3 and can drive bone weakening and blood vessel calcification long before dialysis is ever considered. Catching it early opens the door to dietary phosphorus restriction and, if needed, phosphate binders.

Elevated glucose alongside a borderline or low eGFR is a warning that the kidneys may already be experiencing damage from blood sugar. If glucose is high and eGFR is trending down, adding a hemoglobin A1c (HbA1c) test and a urine albumin check becomes a priority.

When Results Can Be Misleading

Acute illness, intense exercise, and dehydration can temporarily shift nearly every marker on this panel. A hard workout the day before your draw can raise creatinine, BUN, and potassium while lowering bicarbonate. A viral illness with vomiting or diarrhea can distort sodium, potassium, and BUN through fluid loss alone. These are transient effects, not kidney disease.

Certain medications also move these numbers. ACE inhibitors and ARBs (common blood pressure medications) can raise potassium and creatinine slightly as an expected effect of the medication. Diuretics (water pills) can lower sodium and potassium. Proton pump inhibitors used for acid reflux can lower magnesium and, in some cases, affect kidney function over time. Always note any medications when reviewing results.

Creatinine is the marker most vulnerable to misinterpretation from body composition. A very muscular person may show elevated creatinine and a falsely low eGFR. A person with very low muscle mass, including many older adults, may have normal creatinine despite real kidney damage. This is precisely why the panel includes cystatin C: it is not affected by muscle mass and serves as a corrective lens.

Tracking Over Time

A single snapshot of kidney function is useful, but serial tracking is where this panel becomes powerful. CKD is defined not just by a single low eGFR, but by an abnormality that persists for three months or more. A single borderline eGFR of 58 could be a lab artifact or a transient dip from dehydration. Two readings of 58 three months apart confirm a real problem.

Trending your electrolytes over time also catches slow drifts that a single test would miss. A bicarbonate level of 23 is normal. But if it was 26 a year ago and 24 six months ago, the downward trend suggests the kidneys are gradually losing their acid-handling capacity, even though every individual reading falls within the reference range.

For adults with no known kidney disease and no major risk factors, annual testing is reasonable. If you have diabetes, high blood pressure, a family history of kidney disease, or any prior abnormal result, every six months is a better interval. The goal is to detect a trajectory change early enough to intervene.

What to Do with Your Results

If all results fall within their reference ranges and your eGFR is above 90, your kidneys are performing well. Retest annually to maintain your baseline.

If eGFR is between 60 and 89, confirm with a cystatin C-based calculation (which this panel provides). If the combined eGFR still shows a mild reduction, add a urine albumin-to-creatinine ratio (UACR). Kidney damage often shows up in the urine before the blood markers change dramatically. An eGFR below 60 confirmed on two occasions, or any eGFR paired with elevated urine albumin, warrants a consultation with a nephrologist (kidney specialist).

If bicarbonate is low, talk to your doctor about supplementation. If phosphorus is rising, review dietary phosphorus sources and discuss whether a parathyroid hormone (PTH) check is warranted. If glucose is elevated, add HbA1c and begin or intensify blood sugar management. Each abnormal result on this panel has a clear next step, and acting on these signals early is what separates routine testing from genuine prevention.